IGC Pharma, Inc.
IGC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001326205
No open-market purchases or sales by IGC Pharma, Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $1.41M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding IGC Pharma, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 27 | 25 | −2 |
| Shares | 2.82M | 2.47M | −356.1K (−12.6%) |
| Value | $1.01M | $691.3K | −$322.1K (−31.8%) |
New holders (5)
Institutions that held IGC Pharma, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| JPMorgan Chase & Co | 4,917 | $1.38K | 0.00% |
| Game Plan Financial Advisors, LLC | 500 | $140 | 0.00% |
| Caitlin John, LLC | 200 | $56 | 0.00% |
| FMR LLC | 156 | $44 | 0.00% |
| GWM Advisors LLC | 25 | $7 | 0.00% |
Sold out (7)
Institutions that held IGC Pharma, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Commonwealth Equity Services, LLC | 165,490 | $59.0K |
| Renaissance Technologies LLC | 86,902 | $31.0K |
| Two Sigma Securities, LLC | 47,750 | $17.2K |
| Jane Street Group, LLC | 46,540 | $16.7K |
| HRT Financial LP | 18,148 | $6.00K |
| Millennium Management LLC | 14,276 | $5.13K |
| Bank of America Corp | 250 | $90 |